Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer.

Pawul W, Opoka P, Dusza A, Blajerski B, Orzelska J, Gierulska N, Kułak K, Tarkowski R

Open source

DOI
10.3389/fonc.2026.1899836
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1899836,
  title = {Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer.},
  author = {Pawul W and Opoka P and Dusza A and Blajerski B and Orzelska J and Gierulska N and Kułak K and Tarkowski R},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1899836},
  url = {https://doi.org/10.3389/fonc.2026.1899836}
}

RIS

TY  - JOUR
TI  - Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer.
AU  - Pawul W
AU  - Opoka P
AU  - Dusza A
AU  - Blajerski B
AU  - Orzelska J
AU  - Gierulska N
AU  - Kułak K
AU  - Tarkowski R
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1899836
UR  - https://doi.org/10.3389/fonc.2026.1899836
ER  - 

APA

W, P., P, O., A, D., B, B., J, O., N, G., K, K., & R, T. (2026). Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1899836

Source records